Pingdingshan First People's Hospital

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Stroke2 trials
• Hepatitis B1 trial
• Immune thrombocytopenia (ITP)1 trial
• Liver and biliary tract cancer1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Recruiting3 trials
• Completed1 trial

Lead sponsor

• Beijing Tiantan Hospital1 trial
• Dongzhimen Hospital, Beijing1 trial
• Hangzhou Sumgen Biotech Co., Ltd.1 trial
• The First Affiliated Hospital of Zhengzhou University1 trial

Running trials

• Recruiting

  SG301-SC Injection Safety Study in Subjects With Primary ITP Patients

  NCT07710248· Phase 2· Hangzhou Sumgen Biotech Co., Ltd.· Source

  Contact: Zhanfang Wang, Doctor

• Recruiting

  Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.

  NCT07169656· The First Affiliated Hospital of Zhengzhou University· Source

  Contact: Hongde Ma

• Recruiting

  Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)

  NCT06157502· Phase 3· Beijing Tiantan Hospital· Source

  Contact: Enhui Guo

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Hepatitis B1 recruiting
• Immune thrombocytopenia (ITP)1 recruiting
• Liver and biliary tract cancer1 recruiting
• Stroke1 recruiting

Closed trials

• Completed

  Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice

  NCT06018181· Dongzhimen Hospital, Beijing· Source